Cita APA

Furubayashi, N., Negishi, T., Yamashita, T., Kusano, S., Taguchi, K., Shimokawa, M., & Nakamura, M. (2017). The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy. Mol Clin Oncol.

Chicago Style Citation

Furubayashi, Nobuki, Takahito Negishi, Takuya Yamashita, Shuhei Kusano, Kenichi Taguchi, Mototsugu Shimokawa, i Motonobu Nakamura. "The Combination of Paclitaxel and Carboplatin As Second-line Chemotherapy Can Be a Preferred Regimen for Patients With Urothelial Carcinoma After the Failure of Gemcitabine and Cisplatin Chemotherapy." Mol Clin Oncol 2017.

Cita MLA

Furubayashi, Nobuki, et al. "The Combination of Paclitaxel and Carboplatin As Second-line Chemotherapy Can Be a Preferred Regimen for Patients With Urothelial Carcinoma After the Failure of Gemcitabine and Cisplatin Chemotherapy." Mol Clin Oncol 2017.